This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2005 Nov;1(1):20-1.

doi: 10.1038/ncpneph0020.

Is lanthanum carbonate safer and more effective than calcium carbonate for hyperphosphatemia in dialysis patients?

Masafumi Fukagawa¹

Affiliations

PMID: 16932360
DOI: 10.1038/ncpneph0020

Comment

Is lanthanum carbonate safer and more effective than calcium carbonate for hyperphosphatemia in dialysis patients?

Masafumi Fukagawa. Nat Clin Pract Nephrol. 2005 Nov.

. 2005 Nov;1(1):20-1.

doi: 10.1038/ncpneph0020.

Author

Masafumi Fukagawa¹

Affiliation

¹ Division of Nephrology and Dialysis Center, Kobe University School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. fukagawa@med.kobe-u.ac.jp

PMID: 16932360
DOI: 10.1038/ncpneph0020

No abstract available

PubMed Disclaimer

Comment on

Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate.
Hutchison AJ, Maes B, Vanwalleghem J, Asmus G, Mohamed E, Schmieder R, Backs W, Jamar R, Vosskuhler A. Hutchison AJ, et al. Nephron Clin Pract. 2005;100(1):c8-19. doi: 10.1159/000084653. Epub 2005 Apr 4. Nephron Clin Pract. 2005. PMID: 15809508 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database